- Home
- VMD vs MRVI Comparison
VMD vs MRVI Comparison
Compare VMD & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- MRVI
- Stock Information
- Founded
- VMD 2006
- MRVI 2014
- Country
- VMD United States
- MRVI United States
- Employees
- VMD N/A
- MRVI N/A
- Industry
- VMD
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- VMD
- MRVI Health Care
- Exchange
- VMD Nasdaq
- MRVI Nasdaq
- Market Cap
- VMD 279.4M
- MRVI 312.4M
- IPO Year
- VMD N/A
- MRVI 2020
- Fundamental
- Price
- VMD $6.62
- MRVI $2.08
- Analyst Decision
- VMD
- MRVI Hold
- Analyst Count
- VMD 0
- MRVI 10
- Target Price
- VMD N/A
- MRVI $6.84
- AVG Volume (30 Days)
- VMD 143.6K
- MRVI 1.5M
- Earning Date
- VMD 08-06-2025
- MRVI 08-06-2025
- Dividend Yield
- VMD N/A
- MRVI N/A
- EPS Growth
- VMD 19.95
- MRVI N/A
- EPS
- VMD 0.30
- MRVI N/A
- Revenue
- VMD $232,793,000.00
- MRVI $241,856,000.00
- Revenue This Year
- VMD $17.35
- MRVI N/A
- Revenue Next Year
- VMD $12.87
- MRVI $10.73
- P/E Ratio
- VMD $22.10
- MRVI N/A
- Revenue Growth
- VMD 19.97
- MRVI N/A
- 52 Week Low
- VMD $6.14
- MRVI $1.67
- 52 Week High
- VMD $9.81
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- VMD 46.22
- MRVI 46.40
- Support Level
- VMD $6.56
- MRVI $2.00
- Resistance Level
- VMD $6.84
- MRVI $2.44
- Average True Range (ATR)
- VMD 0.22
- MRVI 0.15
- MACD
- VMD -0.00
- MRVI -0.03
- Stochastic Oscillator
- VMD 15.07
- MRVI 20.45
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.